Survey finds rising optimism that AI will speed drug discovery

A recent Endpoints News headline, published October 28, 2026, reports that 78% of surveyed scientists expect AI to speed up drug discovery this year. The article appears to be paywalled, and the available results do not provide the survey’s sample size or methodology.

The result fits a broader pattern of rising optimism:
an earlier 2026 biopharma sentiment survey found 74% of respondents expected AI to speed drug discovery over the following 12 months, up from 69% the previous quarter.

The figures describe expectations, not proof that AI has already accelerated the full path from discovery to approved medicines. Other reporting notes that AI may speed early research, while experiments, clinical development, and validation remain important bottlenecks.